Results for ''
People with longstanding kidney disease face health issues like heart disease and diabetes that could impact their risk of severe COVID-19 and life expectancy, according to a new study enabled by...
A large-scale clinical trial of a monoclonal antibody treatment for COVID-19 showed that it could reduce deaths by 21 per cent in people who had not mounted a natural antibody response of their own.
Five research teams tell us their top insights from our rapid COVID-19 funding call, established in December 2020 to harness the power of UK data to improve lives in the pandemic and beyond.
Early on in the pandemic, reports started emerging that ethnic minority groups were at greater risk of COVID-19. This project looked at data from healthcare records and linked it to national...
Analysis of community cohort studies linked to national testing data to understand how COVID-19 spreads at home, work, school and other public places and if this is affected by age, ethnic...
The pandemic changed the way we work. This project looked to understand how the pandemic impacted the working lives of women and men differently, focusing on job loss, precarious work and...
The Covid-19 pandemic continues to cause a huge strain on health care services, including palliative care, which aims to control symptoms and reduce suffering when patients cannot be cured. This...
Researchers used national data sets to answer questions at the start of the pandemic about who was being vaccinated, what kind of protection from COVID-19 they offered, and how safe they were on a...
New paper from EAVE II team uses linked GP, hospital and lab data to analyse severity of omicron variant and effectiveness of vaccine boosters against symptomatic disease in Scotland
